Across TCGA pan-cancer cohorts, RBM26-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RBM26-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where RBM26-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types RBM26-AS1 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.
THCA, KIRC, and LUAD are the cancer types where RBM26-AS1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM26-AS1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.